Cargando…

NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma

BACKGROUND: Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model that mimics this translocation event by inserting a mouse Myc cDNA gene into...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seong-Su, Yun, Hwakyung, Son, Dong-Ju, Tompkins, Van S, Peng, Liangping, Chung, Seung-Tae, Kim, Joong-Su, Park, Eun-Sung, Janz, Siegfried
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876994/
https://www.ncbi.nlm.nih.gov/pubmed/20433747
http://dx.doi.org/10.1186/1476-4598-9-97
_version_ 1782181744023175168
author Han, Seong-Su
Yun, Hwakyung
Son, Dong-Ju
Tompkins, Van S
Peng, Liangping
Chung, Seung-Tae
Kim, Joong-Su
Park, Eun-Sung
Janz, Siegfried
author_facet Han, Seong-Su
Yun, Hwakyung
Son, Dong-Ju
Tompkins, Van S
Peng, Liangping
Chung, Seung-Tae
Kim, Joong-Su
Park, Eun-Sung
Janz, Siegfried
author_sort Han, Seong-Su
collection PubMed
description BACKGROUND: Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model that mimics this translocation event by inserting a mouse Myc cDNA gene into the immunoglobulin heavy chain locus, just upstream of the intronic Eμ enhancer. These mice, designated iMyc(Eμ), readily develop B-cell lymphoma. To study the mechanism of Myc-induced lymphoma, we analyzed signaling pathways in lymphoblastic B-cell lymphomas (LBLs) from iMyc(Eμ )mice, and an LBL-derived cell line, iMyc(Eμ)-1. RESULTS: Nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) were constitutively activated in iMyc(Eμ )mice, not only in LBLs but also in the splenic B-lymphocytes of young animals months before tumors developed. Moreover, inhibition of either transcription factor in iMyc(Eμ)-1 cells suppressed growth and caused apoptosis, and the abrogation of NF-κB activity reduced DNA binding by both STAT3 and Myc, as well as Myc expression. Inhibition of STAT3 signaling eliminated the activity of both NF-κB and Myc, and resulted in a corresponding decrease in the level of Myc. Thus, in iMyc(Eμ)-1 cells NF-κB and STAT3 are co-dependent and can both regulate Myc. Consistent with this, NF-κB and phosphorylated STAT3 were physically associated with one another. In addition, LBLs and iMyc(Eμ)-1 cells also showed constitutive AKT phosphorylation. Blocking AKT activation by inhibiting PI3K reduced iMyc(Eμ)-1 cell proliferation and caused apoptosis, via downregulation of NF-κB and STAT3 activity and a reduction of Myc levels. Co-treatment with NF-κB, STAT3 or/and PI3K inhibitors led to additive inhibition of iMyc(Eμ)-1 cell proliferation, suggesting that these signaling pathways converge. CONCLUSIONS: Our findings support the notion that constitutive activation of NF-κB and STAT3 depends on upstream signaling through PI3K, and that this activation is important for cell survival and proliferation, as well as for maintaining the level of Myc. Together, these data implicate crosstalk among NF-κB, STAT3 and PI3K in the development of iMyc(Eμ )B-cell lymphomas.
format Text
id pubmed-2876994
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28769942010-05-27 NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma Han, Seong-Su Yun, Hwakyung Son, Dong-Ju Tompkins, Van S Peng, Liangping Chung, Seung-Tae Kim, Joong-Su Park, Eun-Sung Janz, Siegfried Mol Cancer Research BACKGROUND: Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model that mimics this translocation event by inserting a mouse Myc cDNA gene into the immunoglobulin heavy chain locus, just upstream of the intronic Eμ enhancer. These mice, designated iMyc(Eμ), readily develop B-cell lymphoma. To study the mechanism of Myc-induced lymphoma, we analyzed signaling pathways in lymphoblastic B-cell lymphomas (LBLs) from iMyc(Eμ )mice, and an LBL-derived cell line, iMyc(Eμ)-1. RESULTS: Nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) were constitutively activated in iMyc(Eμ )mice, not only in LBLs but also in the splenic B-lymphocytes of young animals months before tumors developed. Moreover, inhibition of either transcription factor in iMyc(Eμ)-1 cells suppressed growth and caused apoptosis, and the abrogation of NF-κB activity reduced DNA binding by both STAT3 and Myc, as well as Myc expression. Inhibition of STAT3 signaling eliminated the activity of both NF-κB and Myc, and resulted in a corresponding decrease in the level of Myc. Thus, in iMyc(Eμ)-1 cells NF-κB and STAT3 are co-dependent and can both regulate Myc. Consistent with this, NF-κB and phosphorylated STAT3 were physically associated with one another. In addition, LBLs and iMyc(Eμ)-1 cells also showed constitutive AKT phosphorylation. Blocking AKT activation by inhibiting PI3K reduced iMyc(Eμ)-1 cell proliferation and caused apoptosis, via downregulation of NF-κB and STAT3 activity and a reduction of Myc levels. Co-treatment with NF-κB, STAT3 or/and PI3K inhibitors led to additive inhibition of iMyc(Eμ)-1 cell proliferation, suggesting that these signaling pathways converge. CONCLUSIONS: Our findings support the notion that constitutive activation of NF-κB and STAT3 depends on upstream signaling through PI3K, and that this activation is important for cell survival and proliferation, as well as for maintaining the level of Myc. Together, these data implicate crosstalk among NF-κB, STAT3 and PI3K in the development of iMyc(Eμ )B-cell lymphomas. BioMed Central 2010-04-30 /pmc/articles/PMC2876994/ /pubmed/20433747 http://dx.doi.org/10.1186/1476-4598-9-97 Text en Copyright ©2010 Han et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Han, Seong-Su
Yun, Hwakyung
Son, Dong-Ju
Tompkins, Van S
Peng, Liangping
Chung, Seung-Tae
Kim, Joong-Su
Park, Eun-Sung
Janz, Siegfried
NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma
title NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma
title_full NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma
title_fullStr NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma
title_full_unstemmed NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma
title_short NF-κB/STAT3/PI3K signaling crosstalk in iMyc(Eμ )B lymphoma
title_sort nf-κb/stat3/pi3k signaling crosstalk in imyc(eμ )b lymphoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876994/
https://www.ncbi.nlm.nih.gov/pubmed/20433747
http://dx.doi.org/10.1186/1476-4598-9-97
work_keys_str_mv AT hanseongsu nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT yunhwakyung nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT sondongju nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT tompkinsvans nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT pengliangping nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT chungseungtae nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT kimjoongsu nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT parkeunsung nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma
AT janzsiegfried nfkbstat3pi3ksignalingcrosstalkinimycemblymphoma